Real-World Immunosuppressant Treatment Patterns for Patients with Lupus Nephritis in the United States.

Hunnicutt, Jacob N; Georgiou, Mary Elizabeth; Ma, Liyuan; Levy, Roger A; Gairy, Kerry

Hunnicutt, Jacob N; Georgiou, Mary Elizabeth; Ma, Liyuan; Levy, Roger A; Gairy, Kerry.

Afiliación

Hunnicutt JN; GSK, Value Evidence and Outcomes, 1250 South Collegeville Road, Collegeville, PA, 19426, USA. jacob.n.hunnicutt@gsk.com.
Georgiou ME; GSK, Value Evidence and Outcomes, Brentford, Middlesex, UK.
Ma L; GSK, Value Evidence and Outcomes, Collegeville, PA, USA.
Levy RA; GSK, Global Medical Affairs, Collegeville, PA, USA.
Gairy K; GSK, Value Evidence and Outcomes, Brentford, Middlesex, UK.

Rheumatol Ther ; 10(5): 1305-1318, 2023 Oct.

Article en En | MEDLINE | ID: mdl-37477809

Palabras clave

Corticosteroids; Induction treatment; Lupus nephritis; Maintenance treatment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Rheumatol Ther Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google